Insider Selling: Cytokinetics (NASDAQ:CYTK) CEO Sells 7,500 Shares of Stock
Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) CEO Robert Blum sold 7,500 shares of the business's stock in a transaction on Wednesday, April 15th. The shares were sold at an average price of $65.38, for a total transaction of $490,350.00. Following the sale, the chief executive officer...